Other states allow asynchronous consultations (secure messaging) for GLP-1 prescribing
Ros team manages insurance approvals for Wegovy, Ozempic, Zepbound, and Saxenda
Your healthcare provider will monitor your weight loss progress, blood sugar levels (if you have diabetes), and overall health to assess the effectiveness of GLP-1 analogues
Regulatory decisions are anticipated in 2026
It directly influences how quickly your medication is absorbed into the subcutaneous fat, how consistently it reaches therapeutic levels in your bloodstream, and whether you develop underlying scar tissue that could blunt the drug's effectiveness over time
Maintaining Long-Term Weight Loss and Building Confidence Beyond the Early Phase Once the first months of treatment produce visible progress, the next important stage is sustaining those results